ReviewIndian journal of psychiatry2026
Global and regional level association between depression and glycemic control in type 2 diabetes mellitus: A systematic review and meta-analysis.
Review in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis.Journal of diabetes and metabolic disorders · 2026Review
- Depression, diabetes, and digitally governed integrated public mental health services.Indian journal of psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression and type 2 diabetes mellitus (T2DM) are major global public health concerns. Depression worsens glycemic control through behavioral and biological pathways, increasing insulin resistance and poor adherence to diabetes care. Aim: This systematic review and meta-analysis (SRMA) examined the association between depression and glycemic control among individuals with T2DM worldwide. Materials and Methods: Following PRISMA guidelines, studies published from January 2000 to May 2024 were retrieved from Cochrane, Embase, ProQuest, Web of Science, and PubMed. Thirty-eight studies were included to assess mean differences (MDs) in HbA1c and fasting blood sugar (FBS), proportions with poor glycemic control, and medication adherence among those with and without depression. Random-effects models in R Studio were used, with subgroup and meta-regression analyses addressing heterogeneity. Results: Depressed individuals showed a significant mean increase of 0.30% in HbA1c compared to nondepressed counterparts (95% CI: 0.09-0.51; n = 20). Stronger associations were observed in North American studies, larger sample sizes, and those using Patient Health Questionnaire-9 (PHQ-9) cutoff scores >10. Duration of diabetes significantly influenced the HbA1c difference. No significant association was found for poor glycemic control (OR = 1.74, 95% CI: 0.81-3.73; n = 12), FBS (MD = 24.39, 95% CI: -17.29-66.06; n = 4), or medication adherence (OR = 1.86, 95% CI: 0.57-6.10; n = 5). High heterogeneity (I² > 90%) and publication bias were noted, with GRADE rating the evidence as very low certainty. Conclusion: Depression modestly affects glycemic outcomes in T2DM, with heterogeneity among studies. Higher HbA1c among depressed patients was found with low certainty and to be minimally clinically significant. Methodologies in the included studies emphasize the need for standard approaches and better study designs (prospective cohort studies). Prospero registration number: CRD42024543104, https://www.crd.york.ac.uk/PROSPERO/view/CRD42024543104.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.